Riskpilot← Back to searchSign inGet full accessTransylvania Anna AB
ABActiveOrg 5591295901Rubinvägen 4Medical specialists activities · NACE 8622Est. 20171 employees
Revenue 2025
SEK 375K
-60% vs 2024
EBITDA margin
80.1%
-66% vs 2024
Equity ratio
90.3%
Financial strength
Net profit 2025
SEK 241K
-74% vs 2024
| Revenue | SEK 375K | -60% |
| EBITDA | SEK 301K | -66% |
| Net profit | SEK 241K | -74% |
| Total assets | SEK 1,3M | -23% |
| Equity | SEK 1,1M | +4% |
| Employees | 1 | — |
Legal name
Transylvania Anna AB
Org number
5591295901
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
17 oktober 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Kort- eller långvarig sjukvård vid allmänna sjukhus eller sjukhus med särskild inriktning, sjukvård med diagnostisk och medicinsk behandling av sjukhuspatienter som lider av någon av ett stort antal sjukdomar. Den omfattar också konsultation och behandling inom allmän- och specialistvård som utförs av allmänpraktiserande läkare och specialister.
Address
Rubinvägen 4
Email
vasstotyi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 429 | 470 | 954 | 950 | 375 |
| Staff expenses | — | — | — | −42 | −34 |
| EBITDA | 392 | 443 | 890 | 876 | 301 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 392 | 443 | 890 | 876 | 301 |
| Net financials | — | — | −478 | 243 | 4 |
| Profit before tax | 392 | 443 | 651 | 1 119 | 305 |
| Tax | −79 | −91 | −185 | −182 | −64 |
| Net profit | 313 | 352 | 466 | 937 | 241 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 581 | 1 039 | 1 061 | 1 619 | 1 253 |
| Equity | 386 | 738 | 554 | 1 091 | 1 132 |
| Long-term debt | 12 | 24 | 60 | 100 | 34 |
| Short-term debt | 184 | 278 | 448 | 427 | 87 |
| Total debt | 196 | 302 | 508 | 528 | 121 |
EBITDA margin
80.1%
This company
15.8%
Market median
+407% vs market
20212025
Equity ratio
90.3%
This company
38.2%
Market median
+136% vs market
20212025
Return on equity
21.3%
This company
18.4%
Market median
+16% vs market
20212025
Net profit margin
64.2%
This company
8.1%
Market median
+693% vs market
20212025
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Transylvania Anna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Klára Enikö Bálint | Deputy Board Member | 0 companies |
| Károly Vass | Board of Directors | 0 companies |